It's not a good time for medication, two batches of a cancer drug have been withdrawn, the same pharmacies have voluntarily recalled it, it is the drug specialty Mitomycin Medac.
Let's see what are the characteristics of the drug and any withdrawn batches
Let's look at the characteristics of the drug on alert. The medical specialty is Mitomicina Medac from Medac Pharma in Rome. We can see exactly which batches are affected:
1) Lot No C0180101A to 31.03.2020, 1 mg / ml powder for solution for injection / infusion or for intravesical use AIC 044530107
2) Lot number D180101A until 31.03.2020 , 1 mg / ml powder for solution for injection / infusion or for intravesical use AIC 0445301
Mitomycin is recommended for the treatment of some types of neoplasia Communication from the same company Medac Pharma srl on an increase of invisible particles
It will It is recommended that consumers exercise extreme caution when using this medicine. If you have parcels of the medicine on alert, you only need to check that you are not part of these alert batches. If instead they correspond to the reported lots, you only have to return them to the place where you bought them. Then it will be changed to a drug that is not on alert, or a full refund will be requested. There is no purchase receipt required.
Withdrawal drug against carcinogenic impurities: here are brand and quantity
To keep up to date, follow us on: Facebook – Twitter Gnews – Telegram – Instragram – Pinterest – Youtube – Contact us on WhatsApp under the new number 3516559380 – Enter this number in the address book and send us the following message via WhatsApp: "news" , we will answer as soon as possible.